Cobomarsen T39294
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 1848257-52-2 | ¥17,000.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Cobomarsen
描述: Cobomarsen (MRG-106) is an oligonucleotide inhibitor targeting miR-155. This compound effectively suppresses various gene pathways involved in cell survival, such as JAK/STAT, MAPK/ERK, and PI3K/AKT. Cobomarsen is particularly valuable in the study of B-cell lymphoma.
体外活性: Cobomarsen (10 μM; 48-96 h) reduces cell proliferation and induces apoptosis in U2932, OCI-LY3, and RCK8 cells[2]. Cobomarsen (10 μM; 72 h) significantly increases the expression of the four direct targets in the cell lines that overexpress miR-155[1]. Cobomarsen (10 μM; 12 days) reduces cellular proliferation and induces apoptosis in MF and HTLV-1+ CTCL cells[1]. Cobomarsen (10-50 μM; 7 days) reduces phosphorylation of the downstream signalling proteins AKT, ERK1/2, and STAT-3 in primary human activated T cells or MF cell lines[1]. Cell Proliferation Assay[2]Cell Line: U2932, OCI-LY3 and RCK8 cells Concentration: 10 μM Incubation Time: 48, 72, 96 hours Result: Concentration-dependently inhibited cell phosphorylation. Apoptosis Analysis[2]Cell Line: U2932, OCI-LY3 and RCK8 cells Concentration: 10 μM Incubation Time: 96 hours Result: Triggered a significant induction of late apoptosis in all cell lines.
体内活性: Cobomarsen (1 mg/kg; i.v. on days 0, 2, 4, and 7) inhibits tumor growth in mice carrying U2932 cells xenografts[2]. Animal Model: Five-to-six weeks old female NSG mice injected with U2932 cells Dosage: 1 mg/kg Administration: I.v. on days 0, 2, 4, and 7 Result: Reduced tumor growth most significantly at day 7 and day 10.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: MRG106 | MRG 106
Cobomarsen T39294信息由TargetMol中国为您提供,如您想了解更多关于Cobomarsen T39294报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途